Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine 1% eye drops for presbyopia
IRCT20240325061363N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in presbyopia comparing Pilocarpine 1% eye drops with Artificial tear eye drops (2 arms). Primary endpoints: Uncorrected near visual acuity and Uncorrected distance visual acuity. Started Apr 2024; status: completed.
02
Drugs
pilocarpinehypromellose
03
Conditions
presbyopia
Beyond the preview
Go deeper on IRCT20240325061363N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240325061363N1.